CLINICAL_TRIALS
trial_result
· 2012-04-16
Clinical Trial Update: Efficacy Trial of 3804-250A in the Prevention of Cold Illnesses [Phase 2]
Summary
A Phase 2 trial evaluating the efficacy of 3804-250A in preventing common cold illnesses has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Dial Corporation | Conditions: Common Cold | Phase 2 | Status: COMPLETED | Results posted: 2012-04-16